Search

Search Constraints

You searched for: Author/Creator Rizzo, Aroldo

Search Results

1. Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease. Issue 9 (17th January 2017)

3. Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis. (7th August 2020)

4. Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis. (28th February 2022)

5. Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis. (9th April 2015)

6. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Issue 6 (9th January 2017)

7. Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis. Issue 1 (20th April 2016)

8. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Issue 8 (5th June 2013)

9. Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis. (23rd May 2020)